Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

被引:90
作者
Aldoss, Ibrahim [1 ]
Yang, Dongyun [2 ]
Pillai, Raju [3 ]
Sanchez, James F. [1 ]
Mei, Matthew [1 ]
Aribi, Ahmed [1 ]
Ali, Haris [1 ]
Sandhu, Karamjeet [1 ]
Al Malki, Monzr M. [1 ]
Salhotra, Amandeep [1 ]
Khaled, Samer [1 ]
Sun, Weili [4 ]
O'Donnell, Margaret [1 ]
Snyder, David [1 ]
Nakamura, Ryotaro [1 ]
Stein, Anthony S. [1 ]
Forman, Stephen J. [3 ]
Marcucci, Guido [1 ]
Pullarkat, Vinod [1 ]
机构
[1] City Hope Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplantat, 1500 East Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Med Ctr, Dept Informat Sci, Duarte, CA USA
[3] City Hope Med Ctr, Dept Pathol, Duarte, CA USA
[4] City Hope Med Ctr, Dept Pediat, Duarte, CA USA
基金
美国国家卫生研究院;
关键词
MUTATIONS; DIAGNOSIS;
D O I
10.1002/ajh.25567
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E253 / E255
页数:3
相关论文
共 6 条
[1]   Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia [J].
Aldoss, Ibrahim ;
Yang, Dongyun ;
Aribi, Ahmed ;
Ali, Haris ;
Sandhu, Karamjeet ;
Al Malki, Monzr M. ;
Mei, Matthew ;
Salhotra, Amandeep ;
Khaled, Samer ;
Nakamura, Ryotaro ;
Snyder, David ;
O'Donnell, Margaret ;
Stein, Anthony S. ;
Forman, Stephen J. ;
Marcucci, Guido ;
Pullarkat, Vinod .
HAEMATOLOGICA, 2018, 103 (09) :E404-E407
[2]   TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients [J].
Bejar, Rafael ;
Lord, Allegra ;
Stevenson, Kristen ;
Bar-Natan, Michal ;
Perez-Ladaga, Albert ;
Zaneveld, Jacques ;
Wang, Hui ;
Caughey, Bennett ;
Stojanov, Petar ;
Getz, Gad ;
Garcia-Manero, Guillermo ;
Kantarjian, Hagop ;
Chen, Rui ;
Stone, Richard M. ;
Neuberg, Donna ;
Steensma, David P. ;
Ebert, Benjamin L. .
BLOOD, 2014, 124 (17) :2705-2712
[3]   Genomics of Acute Myeloid Leukemia Diagnosis and Pathways [J].
Bullinger, Lars ;
Doehner, Konstanze ;
Doehner, Hartmut .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (09) :934-946
[4]   Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].
DiNardo, Courtney D. ;
Pratz, Keith ;
Pullarkat, Vinod ;
Jonas, Brian A. ;
Arellano, Martha ;
Becker, Pamela S. ;
Frankfurt, Olga ;
Konopleva, Marina ;
Wei, Andrew H. ;
Kantarjian, Hagop M. ;
Xu, Tu ;
Hong, Wan-Jen ;
Chyla, Brenda ;
Potluri, Jalaja ;
Pollyea, Daniel A. ;
Letai, Anthony .
BLOOD, 2019, 133 (01) :7-17
[5]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[6]   Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms [J].
Traina, F. ;
Visconte, V. ;
Elson, P. ;
Tabarroki, A. ;
Jankowska, A. M. ;
Hasrouni, E. ;
Sugimoto, Y. ;
Szpurka, H. ;
Makishima, H. ;
O'Keefe, C. L. ;
Sekeres, M. A. ;
Advani, A. S. ;
Kalaycio, M. ;
Copelan, E. A. ;
Saunthararajah, Y. ;
Saad, S. T. Olalla ;
Maciejewski, J. P. ;
Tiu, R. V. .
LEUKEMIA, 2014, 28 (01) :78-87